Gleiss Lutz advised Curaleaf in the transaction while Paul Hastings represented Four 20 Pharma.Curaleaf Holdings, Inc., a leading U.S. provider of consumer products in cannabis, and…
Curaleaf’s Acquisition of Majority Stake and Strategic Partnership With Four 20 Pharma
